Next Weeks Broker Price Targets For Chemours (NYSE:CC)

Elias Hubbard
October 3, 2017

FMR LLC now owns 10,926,459 shares of the specialty chemicals company's stock valued at $241,366,000 after buying an additional 9,046,728 shares during the last quarter. The company has a market capitalization of $9.75 billion, a P/E ratio of 34.52 and a beta of 3.60. This indicator compares the closing price of a stock in relation to the highs and lows over a certain time period. Two Sigma Investments LP now owns 1,767,087 shares of the specialty chemicals company's stock valued at $39,035,000 after buying an additional 802,556 shares during the last quarter.

08/07/2017 - Chemours was upgraded to "neutral" by analysts at UBS. Rothschild Asset Management Inc. acquired a new stake in Chemours during the third quarter valued at approximately $11,591,000. The portion of a company's profit allocated to each outstanding share of common stock was $2.09 a share in the trailing twelve months. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & global trademark & copyright laws. The original version of this report can be read at https://weekherald.com/2017/10/02/chemours-company-the-cc-getting-somewhat-favorable-media-coverage-study-shows.html.

Several brokerages have recently weighed in on CC. Zacks Investment Research lowered shares of Chemours from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, January 17th. Jefferies Group LLC increased their price objective on Chemours Company (The) to $60.00 and gave the company a "buy" rating in a report on Thursday, August 3rd. If the $55.33 price target is reached, the company will be worth $393.20 million more. Finally, Goldman Sachs Group Inc raised shares of Chemours from a "neutral" rating to a "buy" rating in a research report on Monday, February 13th. They may look to the 50-day or 20-day to get a better grasp of what is going on with the stock in the near-term.

More notable recent Chemours Co (NYSE:CC) news were published by: Insurancejournal.com which released: "Legislators Struggle Over How to Handle Chemicals in North Carolina Water" on October 03, 2017, also Fool.com with their article: "Should you buy at the high?" published on July 20, 2017, Latimes.com published: "Officials: Unregulated chemical in groundwater at NC plant" on September 06, 2017.

In other Chemours Company (The) news, SVP David C. Shelton sold 13,337 shares of the business's stock in a transaction on Thursday, August 31st. One of the more popular combinations is to use the 50-day and 200-day moving averages. At the time of writing, the 14-day ADX for Chemours Company (CC) is 17.35. The stock has seen a price of $52.65 according to a recent bid.

Chemours Company (The) (NYSE:CC) last released its quarterly earnings results on Wednesday, August 2nd. Heading into the next quarter, investors will be watching which companies are experiencing positive earnings momentum. The company had revenue of $1.59 billion during the quarter, compared to analysts' expectations of $1.49 billion. Chemours had a net margin of 2.78% and a return on equity of 81.19%. During the same period previous year, the firm posted $0.27 earnings per share. Equities research analysts anticipate that Chemours Company will post $3.51 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date was Tuesday, August 15th. Chemours's dividend payout ratio is now 14.81%. They now have a United States dollars 40 price target on the stock. The stock was sold at an average price of $46.03, for a total transaction of $115,075.00. The disclosure for this sale can be found here. The company had a trading volume of 1,903,036 shares. Chemours Company (CC)'s Williams %R presently stands at 0.00. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER